Negotiated Solutions for Purchasing High-Cost Medicines: A Practitioner’s Guide
September 29, 2022
Across the globe, decision makers at all levels of the health care system agree that patients should be given rapid access to innovative medicines that target life-threatening diseases such as cancer, multiple sclerosis, and hepatitis C. Governments face increasing amounts of pressure to introduce new technologies because of shifting and evolving health challenges. The goal of this Practitioner’s Guide is to provide countries new to MEAs with an insider perspective. It is hoped that the contents of this Guide will lift the veil on the nature of these negotiations and equip countries with the strategies and know-how they need, to successfully negotiate similar agreements.